Table 1.
Baseline Characteristics of Combined STEMI/NSTE-ACS COVID-ACS Registry Cohort (N = 265)∗
| Mean age, yrs | 64.9 ± 12.9 |
| Male | 75.5 (200/265) |
| Hypertension | 66.2 (174/263) |
| Hyperlipidemia | 54.1 (131/242) |
| BMI, kg/m2 | 27.5 ± 4.7 |
| Diabetes | 36.2 (92/265) |
| Smoking status | |
| Current smoker | 27.1 (62/229) |
| Ex-smoker | 27.1 (62/229) |
| Nonsmoker | 45.8 (105/229) |
| Heart failure | 19.3 (49/254) |
| Previous MI | 20.2 (57/258) |
| Previous PCI | 17.5 (46/263) |
| Chronic kidney disease (stages 3–5) | 14.6 (38/260) |
| Lung disease | 16.5 (42/254) |
| Previous stroke | 7.2 (19/265) |
| COVID-19 positive | 74.3 (197/265) |
| COVID-19 high index suspicion | 25.7 (68/265) |
| Killip class III/IV on admission | 17.4 (46/265) |
| Out-of-hospital cardiac arrest | 5.3 (14/265) |
| Admission lactate, mmol/l | 4.1 ± 7.3 |
| Admission lactate >2.0 mmol/l | 61.7 (58/94) |
| Presentation symptoms typical of ACS | 81.4 (214/263) |
| Full PPE worn during procedure | 90.9 (209/230) |
Values are mean ± SD or % (n/N). Denominators not equal to n = 265 are due to incomplete data.
ACS = acute coronary syndrome; BMI = body mass index; COVID-19 = coronavirus disease 2019; MI = myocardial infarction; NSTE-ACS = non–ST-segment elevation acute coronary syndrome; PCI = percutaneous coronary intervention; PPE = personal protective equipment; STEMI = ST-segment elevation myocardial infarction.
∗
Excludes patients with type 2 myocardial infarction (see Figure 1).